IIA
CRBP icon

IPG Investment Advisors’s Corbus Pharmaceuticals CRBP Stock Holding History

IPG Investment Advisors’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-533
Closed -$111K – 147
2019
Q1 		$111K Buy
+533
New +$118K 0.04% 141
2017
Q2 		– Sell
-442
Closed -$109K – 143
2017
Q1 		$109K Buy
+442
New +$108K 0.05% 127

Other funds holding CRBP

EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

IPG Investment Advisors's CRBP Position: Q2 2019 in Review

IPG Investment Advisors sold out of Corbus Pharmaceuticals (CRBP) in Q2 2019, closing a stake of 533 shares — an estimated $111K sold.

IPG Investment Advisors first reported a position in CRBP in Q1 2017 and held it in 2 quarters. The position peaked at $111K in Q1 2019. 103 funds tracked by Wall St. Rank hold CRBP as of Q2 2019.

  • IPG Investment Advisors reported no remaining Corbus Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • IPG Investment Advisors sold 533 Corbus Pharmaceuticals shares in Q2 2019, an estimated $111K.
  • IPG Investment Advisors first reported a position in Corbus Pharmaceuticals in Q1 2017 and held it in 2 quarters.
  • IPG Investment Advisors's Corbus Pharmaceuticals position peaked at $111K in Q1 2019.
  • 103 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2019.

Based on IPG Investment Advisors's 13F filing for Q2 2019, filed 12 Aug 2019.